Vitamin D and COVID‐19: It is time to act
Andrius Bleizgys
Abstract
Vitamin D (VitD) deficiency is considered a global problem and might be associated with increased susceptibility to COVID-19 illness. In the light of COVID-19 pandemic, VitD might be a promising agent for fighting the SARS-CoV-2, since VitD is involved in various pathophysiological mechanisms that occur during COVID-19 infection. High-dose VitD supplementation, particularly for risk groups, could be recommended to achieve and maintain optimal (range 40-60 ng/mL) serum 25-hydroxy vitamin D levels (marker of VitD status) both for COVID-19 prevention and treatment.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVitamin D and neurologyBetacoronavirusPathophysiologyVitaminInternal medicineVirologyDiseaseInfectious disease (medical specialty)OutbreakVitamin D Research StudiesVitamin C and Antioxidants ResearchCOVID-19 Clinical Research Studies